ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Valsartan Capsules Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-28K18297
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Valsartan Capsules Market Research Report 2024
BUY CHAPTERS

Global Valsartan Capsules Market Research Report 2024

Code: QYRE-Auto-28K18297
Report
November 2024
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Lepu Medical
Novartis
Mylan NV
Teva Pharmaceutical Industries
Torrent Pharmaceuticals
Sun Pharmaceutical
Conquer
Cisen Pharmaceutical
Dynemed

Valsartan Capsules Market

Valsartan capsules are a type of medication belonging to the class of drugs known as angiotensin receptor blockers (ARBs). ARBs work by blocking the action of a hormone called angiotensin II, which narrows blood vessels. By blocking this hormone, valsartan helps to relax blood vessels, lower blood pressure, and reduce the workload on the heart.
The global Valsartan Capsules market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Valsartan Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valsartan Capsules is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valsartan Capsules include Lepu Medical, Novartis, Mylan, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, Sun Pharmaceutical, Dynemed, Conquer, Cisen Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Valsartan Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan Capsules.
The Valsartan Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Valsartan Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valsartan Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Valsartan Capsules Market Report

Report Metric Details
Report Name Valsartan Capsules Market
Segment by Type
  • 40 Mg
  • 80 Mg
  • 160 Mg
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Lepu Medical, Novartis, Mylan, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, Sun Pharmaceutical, Dynemed, Conquer, Cisen Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Valsartan Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Valsartan Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Valsartan Capsules Market report?

Ans: The main players in the Valsartan Capsules Market are Lepu Medical, Novartis, Mylan, Teva Pharmaceutical Industries, Torrent Pharmaceuticals, Sun Pharmaceutical, Dynemed, Conquer, Cisen Pharmaceutical

What are the Application segmentation covered in the Valsartan Capsules Market report?

Ans: The Applications covered in the Valsartan Capsules Market report are Treatment of Hypertension, Treatment of Heart Disease, Others

What are the Type segmentation covered in the Valsartan Capsules Market report?

Ans: The Types covered in the Valsartan Capsules Market report are 40 Mg, 80 Mg, 160 Mg, Others

Recommended Reports

Capsule Pharmaceutical Markets

Hypertension & Heart Drugs

Sartans & ARBs Markets

1 Valsartan Capsules Market Overview
1.1 Product Definition
1.2 Valsartan Capsules by Type
1.2.1 Global Valsartan Capsules Market Value Comparison by Type (2024-2030)
1.2.2 40 Mg
1.2.3 80 Mg
1.2.4 160 Mg
1.2.5 Others
1.3 Valsartan Capsules by Application
1.3.1 Global Valsartan Capsules Market Value by Application (2024-2030)
1.3.2 Treatment of Hypertension
1.3.3 Treatment of Heart Disease
1.3.4 Others
1.4 Global Valsartan Capsules Market Size Estimates and Forecasts
1.4.1 Global Valsartan Capsules Revenue 2019-2030
1.4.2 Global Valsartan Capsules Sales 2019-2030
1.4.3 Global Valsartan Capsules Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valsartan Capsules Market Competition by Manufacturers
2.1 Global Valsartan Capsules Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valsartan Capsules Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valsartan Capsules Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Valsartan Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valsartan Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valsartan Capsules, Product Type & Application
2.7 Global Key Manufacturers of Valsartan Capsules, Date of Enter into This Industry
2.8 Global Valsartan Capsules Market Competitive Situation and Trends
2.8.1 Global Valsartan Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Valsartan Capsules Players Market Share by Revenue
2.8.3 Global Valsartan Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Valsartan Capsules Market Scenario by Region
3.1 Global Valsartan Capsules Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valsartan Capsules Sales by Region: 2019-2030
3.2.1 Global Valsartan Capsules Sales by Region: 2019-2024
3.2.2 Global Valsartan Capsules Sales by Region: 2025-2030
3.3 Global Valsartan Capsules Revenue by Region: 2019-2030
3.3.1 Global Valsartan Capsules Revenue by Region: 2019-2024
3.3.2 Global Valsartan Capsules Revenue by Region: 2025-2030
3.4 North America Valsartan Capsules Market Facts & Figures by Country
3.4.1 North America Valsartan Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valsartan Capsules Sales by Country (2019-2030)
3.4.3 North America Valsartan Capsules Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Valsartan Capsules Market Facts & Figures by Country
3.5.1 Europe Valsartan Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valsartan Capsules Sales by Country (2019-2030)
3.5.3 Europe Valsartan Capsules Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valsartan Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Valsartan Capsules Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valsartan Capsules Sales by Region (2019-2030)
3.6.3 Asia Pacific Valsartan Capsules Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Valsartan Capsules Market Facts & Figures by Country
3.7.1 Latin America Valsartan Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valsartan Capsules Sales by Country (2019-2030)
3.7.3 Latin America Valsartan Capsules Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Valsartan Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Valsartan Capsules Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valsartan Capsules Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valsartan Capsules Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valsartan Capsules Sales by Type (2019-2030)
4.1.1 Global Valsartan Capsules Sales by Type (2019-2024)
4.1.2 Global Valsartan Capsules Sales by Type (2025-2030)
4.1.3 Global Valsartan Capsules Sales Market Share by Type (2019-2030)
4.2 Global Valsartan Capsules Revenue by Type (2019-2030)
4.2.1 Global Valsartan Capsules Revenue by Type (2019-2024)
4.2.2 Global Valsartan Capsules Revenue by Type (2025-2030)
4.2.3 Global Valsartan Capsules Revenue Market Share by Type (2019-2030)
4.3 Global Valsartan Capsules Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valsartan Capsules Sales by Application (2019-2030)
5.1.1 Global Valsartan Capsules Sales by Application (2019-2024)
5.1.2 Global Valsartan Capsules Sales by Application (2025-2030)
5.1.3 Global Valsartan Capsules Sales Market Share by Application (2019-2030)
5.2 Global Valsartan Capsules Revenue by Application (2019-2030)
5.2.1 Global Valsartan Capsules Revenue by Application (2019-2024)
5.2.2 Global Valsartan Capsules Revenue by Application (2025-2030)
5.2.3 Global Valsartan Capsules Revenue Market Share by Application (2019-2030)
5.3 Global Valsartan Capsules Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lepu Medical
6.1.1 Lepu Medical Company Information
6.1.2 Lepu Medical Description and Business Overview
6.1.3 Lepu Medical Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lepu Medical Valsartan Capsules Product Portfolio
6.1.5 Lepu Medical Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Valsartan Capsules Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Valsartan Capsules Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva Pharmaceutical Industries
6.4.1 Teva Pharmaceutical Industries Company Information
6.4.2 Teva Pharmaceutical Industries Description and Business Overview
6.4.3 Teva Pharmaceutical Industries Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceutical Industries Valsartan Capsules Product Portfolio
6.4.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.5 Torrent Pharmaceuticals
6.5.1 Torrent Pharmaceuticals Company Information
6.5.2 Torrent Pharmaceuticals Description and Business Overview
6.5.3 Torrent Pharmaceuticals Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Torrent Pharmaceuticals Valsartan Capsules Product Portfolio
6.5.5 Torrent Pharmaceuticals Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Company Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Valsartan Capsules Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Dynemed
6.7.1 Dynemed Company Information
6.7.2 Dynemed Description and Business Overview
6.7.3 Dynemed Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Dynemed Valsartan Capsules Product Portfolio
6.7.5 Dynemed Recent Developments/Updates
6.8 Conquer
6.8.1 Conquer Company Information
6.8.2 Conquer Description and Business Overview
6.8.3 Conquer Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Conquer Valsartan Capsules Product Portfolio
6.8.5 Conquer Recent Developments/Updates
6.9 Cisen Pharmaceutical
6.9.1 Cisen Pharmaceutical Company Information
6.9.2 Cisen Pharmaceutical Description and Business Overview
6.9.3 Cisen Pharmaceutical Valsartan Capsules Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Cisen Pharmaceutical Valsartan Capsules Product Portfolio
6.9.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valsartan Capsules Industry Chain Analysis
7.2 Valsartan Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valsartan Capsules Production Mode & Process
7.4 Valsartan Capsules Sales and Marketing
7.4.1 Valsartan Capsules Sales Channels
7.4.2 Valsartan Capsules Distributors
7.5 Valsartan Capsules Customers
8 Valsartan Capsules Market Dynamics
8.1 Valsartan Capsules Industry Trends
8.2 Valsartan Capsules Market Drivers
8.3 Valsartan Capsules Market Challenges
8.4 Valsartan Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Lepu Medical
Novartis
Mylan NV
Teva Pharmaceutical Industries
Torrent Pharmaceuticals
Sun Pharmaceutical
Conquer
Cisen Pharmaceutical
Dynemed
List of Tables
 Table 1. Global Valsartan Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Valsartan Capsules Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Valsartan Capsules Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Valsartan Capsules Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Valsartan Capsules Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Valsartan Capsules Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Valsartan Capsules Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Valsartan Capsules Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Valsartan Capsules, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Valsartan Capsules, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Valsartan Capsules, Product Type & Application
 Table 12. Global Key Manufacturers of Valsartan Capsules, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Valsartan Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan Capsules as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Valsartan Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Valsartan Capsules Sales by Region (2019-2024) & (K Dose)
 Table 18. Global Valsartan Capsules Sales Market Share by Region (2019-2024)
 Table 19. Global Valsartan Capsules Sales by Region (2025-2030) & (K Dose)
 Table 20. Global Valsartan Capsules Sales Market Share by Region (2025-2030)
 Table 21. Global Valsartan Capsules Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Valsartan Capsules Revenue Market Share by Region (2019-2024)
 Table 23. Global Valsartan Capsules Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Valsartan Capsules Revenue Market Share by Region (2025-2030)
 Table 25. North America Valsartan Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Valsartan Capsules Sales by Country (2019-2024) & (K Dose)
 Table 27. North America Valsartan Capsules Sales by Country (2025-2030) & (K Dose)
 Table 28. North America Valsartan Capsules Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Valsartan Capsules Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Valsartan Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Valsartan Capsules Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe Valsartan Capsules Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe Valsartan Capsules Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Valsartan Capsules Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Valsartan Capsules Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Valsartan Capsules Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific Valsartan Capsules Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific Valsartan Capsules Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Valsartan Capsules Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Valsartan Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Valsartan Capsules Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America Valsartan Capsules Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America Valsartan Capsules Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Valsartan Capsules Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Valsartan Capsules Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Valsartan Capsules Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa Valsartan Capsules Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa Valsartan Capsules Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Valsartan Capsules Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Valsartan Capsules Sales (K Dose) by Type (2019-2024)
 Table 51. Global Valsartan Capsules Sales (K Dose) by Type (2025-2030)
 Table 52. Global Valsartan Capsules Sales Market Share by Type (2019-2024)
 Table 53. Global Valsartan Capsules Sales Market Share by Type (2025-2030)
 Table 54. Global Valsartan Capsules Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Valsartan Capsules Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Valsartan Capsules Revenue Market Share by Type (2019-2024)
 Table 57. Global Valsartan Capsules Revenue Market Share by Type (2025-2030)
 Table 58. Global Valsartan Capsules Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Valsartan Capsules Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Valsartan Capsules Sales (K Dose) by Application (2019-2024)
 Table 61. Global Valsartan Capsules Sales (K Dose) by Application (2025-2030)
 Table 62. Global Valsartan Capsules Sales Market Share by Application (2019-2024)
 Table 63. Global Valsartan Capsules Sales Market Share by Application (2025-2030)
 Table 64. Global Valsartan Capsules Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Valsartan Capsules Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Valsartan Capsules Revenue Market Share by Application (2019-2024)
 Table 67. Global Valsartan Capsules Revenue Market Share by Application (2025-2030)
 Table 68. Global Valsartan Capsules Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Valsartan Capsules Price (US$/Dose) by Application (2025-2030)
 Table 70. Lepu Medical Company Information
 Table 71. Lepu Medical Description and Business Overview
 Table 72. Lepu Medical Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Lepu Medical Valsartan Capsules Product
 Table 74. Lepu Medical Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Novartis Valsartan Capsules Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Mylan Valsartan Capsules Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Teva Pharmaceutical Industries Company Information
 Table 86. Teva Pharmaceutical Industries Description and Business Overview
 Table 87. Teva Pharmaceutical Industries Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Teva Pharmaceutical Industries Valsartan Capsules Product
 Table 89. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 90. Torrent Pharmaceuticals Company Information
 Table 91. Torrent Pharmaceuticals Description and Business Overview
 Table 92. Torrent Pharmaceuticals Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. Torrent Pharmaceuticals Valsartan Capsules Product
 Table 94. Torrent Pharmaceuticals Recent Developments/Updates
 Table 95. Sun Pharmaceutical Company Information
 Table 96. Sun Pharmaceutical Description and Business Overview
 Table 97. Sun Pharmaceutical Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Sun Pharmaceutical Valsartan Capsules Product
 Table 99. Sun Pharmaceutical Recent Developments/Updates
 Table 100. Dynemed Company Information
 Table 101. Dynemed Description and Business Overview
 Table 102. Dynemed Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 103. Dynemed Valsartan Capsules Product
 Table 104. Dynemed Recent Developments/Updates
 Table 105. Conquer Company Information
 Table 106. Conquer Description and Business Overview
 Table 107. Conquer Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 108. Conquer Valsartan Capsules Product
 Table 109. Conquer Recent Developments/Updates
 Table 110. Cisen Pharmaceutical Company Information
 Table 111. Cisen Pharmaceutical Description and Business Overview
 Table 112. Cisen Pharmaceutical Valsartan Capsules Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 113. Cisen Pharmaceutical Valsartan Capsules Product
 Table 114. Cisen Pharmaceutical Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Valsartan Capsules Distributors List
 Table 118. Valsartan Capsules Customers List
 Table 119. Valsartan Capsules Market Trends
 Table 120. Valsartan Capsules Market Drivers
 Table 121. Valsartan Capsules Market Challenges
 Table 122. Valsartan Capsules Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Valsartan Capsules
 Figure 2. Global Valsartan Capsules Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Valsartan Capsules Market Share by Type: 2023 & 2030
 Figure 4. 40 Mg Product Picture
 Figure 5. 80 Mg Product Picture
 Figure 6. 160 Mg Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Valsartan Capsules Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Valsartan Capsules Market Share by Application: 2023 & 2030
 Figure 10. Treatment of Hypertension
 Figure 11. Treatment of Heart Disease
 Figure 12. Others
 Figure 13. Global Valsartan Capsules Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Valsartan Capsules Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Valsartan Capsules Sales (2019-2030) & (K Dose)
 Figure 16. Global Valsartan Capsules Average Price (US$/Dose) & (2019-2030)
 Figure 17. Valsartan Capsules Report Years Considered
 Figure 18. Valsartan Capsules Sales Share by Manufacturers in 2023
 Figure 19. Global Valsartan Capsules Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Valsartan Capsules Players: Market Share by Revenue in Valsartan Capsules in 2023
 Figure 21. Valsartan Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Valsartan Capsules Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Valsartan Capsules Sales Market Share by Country (2019-2030)
 Figure 24. North America Valsartan Capsules Revenue Market Share by Country (2019-2030)
 Figure 25. United States Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Valsartan Capsules Sales Market Share by Country (2019-2030)
 Figure 28. Europe Valsartan Capsules Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Valsartan Capsules Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Valsartan Capsules Revenue Market Share by Region (2019-2030)
 Figure 36. China Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Valsartan Capsules Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Valsartan Capsules Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Valsartan Capsules Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Valsartan Capsules Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Valsartan Capsules by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Valsartan Capsules by Type (2019-2030)
 Figure 55. Global Valsartan Capsules Price (US$/Dose) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Valsartan Capsules by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Valsartan Capsules by Application (2019-2030)
 Figure 58. Global Valsartan Capsules Price (US$/Dose) by Application (2019-2030)
 Figure 59. Valsartan Capsules Value Chain
 Figure 60. Valsartan Capsules Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Valsartan Hydrochlorothiazide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Valsartan Tablets Market Research Report 2024
Valsartan Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sartan series Drugs Market Research Report 2024
Angiotensin II Receptor Blocker ARBs API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sartans Market Research Report 2024
Global Irbesartan Tablets Market Insights Forecast to 2030
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global Sacubitril Valsartan API Market Research Report 2025
Global Renin Angiotensin System RAS Inhibitor Market Research Report 2024
Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AT1 Receptor Antagonists Market Research Report 2024
Global Angiotensin II Receptor Blockers Market Insights Forecast to 2030
lrbesartan Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global N2 Trityl OlMesartan Acid Market Research Report 2024
Global Irbesartan Market Research Report 2024
Global Irbesartan Amlodipine Tablets Market Research Report 2024
Global Renin Inhibitors Market Research Report 2025
Global Resveratrol Capsules Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions